- Previous Rank-
- Revenues ($M)$1,848
- Revenue Percent Change0.9%
- Profits ($M)$111.5
- Profits Percent Change-47.5%
- Assets ($M)$3,091
- Employees9,200
- Market Value — as of March 31, 2017 ($M)$3,534
Looking for leads, investment insights, or competitive intelligence?Get Premium Access
Company Info
| CEO | John R. Chiminski |
| CEO Title | Chairman & Chief Executive Officer |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| HQ Location | Somerset, NJ |
| Website | http://www.catalent.com |
| Years on Fortune 500 List | - |
| Employees | 9,200 |
Figures are for fiscal year ended June 30, 2016.
Catalent Rank History
Key Financials (Last Fiscal Year)
| $ millions | % change | |
|---|---|---|
| Revenues ($M) | $1,848 | 0.9% |
| Profits ($M) | $111.5 | -47.5% |
| Assets ($M) | $3,091 | - |
| Total Stockholder Equity ($M) | $636 | - |
| Market Value — as of March 31, 2017 ($M) | $3,534 | - |
Profit Ratios
| Profit as % of Revenues | 6% |
| Profits as % of Assets | 3.6% |
| Profits as % of Stockholder Equity | 17.5% |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 0.89 |
| EPS % Change (from 2015) | -49.1% |
| EPS % Change (5 year annual rate) | - |
| EPS % Change (10 year annual rate) | - |
Total Return
| Total Return to Investors (2016) | 7.7% |
| Total Return to Investors (5 year, annualized) | - |
| Total Return to Investors (10 year, annualized) | - |
